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Laboratory strains of viruses may contain cell culture-adaptive mutations which result in significant
quantitative and qualitative alterations in pathogenesis compared to natural virus isolates. This report
suggests that this is the case with Sindbis virus strain AR339. A cDNA clone comprising a consensus sequence
of Sindbis virus strain AR339 has been constructed (W. B. Klimstra, K. D. Ryman, and R. E. Johnston, J. Virol.
72:7357–7366, 1998). This clone (pTR339) regenerates a sequence predicted to be very close to that of the
original AR339 isolate by eliminating several cell culture-adaptive mutations present in individual laboratory
strains of the virus (K. L. McKnight et al., J. Virol. 70:1981–1989, 1996). It thus provides a unique reagent for
study of the pathogenesis of Sindbis virus strain AR339 in mice. Neonatal mouse pathogenesis of virus (TR339)
generated from the pTR339 clone was compared with that of virus from a cDNA clone of the cell culture-
passaged laboratory AR339 strain, TRSB, and virus from a clone of a more highly cell culture-adapted strain,
HRsp (Toto 50). The sequence of TRSB differs from the consensus at three coding positions, while Toto 50
differs at eight codons and one nucleotide in the 5* nontranslated region. Both cell culture-adapted strains
contain mutations associated with heparan sulfate (HS)-dependent attachment to cells (W. B. Klimstra, K. D.
Ryman, and R. E. Johnston, J. Virol. 72:7357–7366, 1998). TR339 caused 100% mortality with an average
survival time (AST) of 1.7 6 0.25 days. While TRSB also caused 100% mortality, the AST was extended to 2.9 6
0.52 days. The more extensively cell culture-adapted virus Toto 50 caused only 30% mortality with an AST
extended to 11.0 6 4.8 days. TRSB and TR339 induced high serum levels of alpha/beta interferon, gamma
interferon, tumor necrosis factor alpha, interleukin-6, and corticosterone and induced pathology reminiscent
of lipopolysaccharide-induced endotoxic shock, a type of systemic inflammatory response syndrome. However,
the reduced intensity of this response in TRSB-infected mice correlated with the increased AST. Toto 50 failed
to induce the shock-like cytokine cascade. In situ hybridization studies indicated that TR339 and TRSB
replicated in identical tissues, but the TRSB signal was less widespread at early times postinfection. While Toto
50 also replicated in similar tissues, the extent of replication was severely restricted and mice developed lesions
characteristic of encephalitis. A single mutation in TRSB at E2 position 1 (Arg) conferred HS-dependent
attachment to cells and was associated with reduced cytokine induction and extended AST in vivo.
Sindbis virus, the prototype member of the Alphavirus genus,
is a positive-sense RNA virus with a genome of 11,703 nucle-
otides (55). Sindbis virus strain AR339, originally isolated in
1952 in Sindbis, Egypt (57), has been used extensively in in
vitro studies of the alphavirus life cycle and in studies of its
pathogenesis in mice (28, 40, 51, 61). Virtually all of these
studies have employed either biological strains derived after
passage of Sindbis virus strain AR339 in cultured cells or virus
derived from cDNA clones of such passaged viruses (31).
Some laboratory isolates of Sindbis virus strain AR339 cause
a rapidly fatal disease in neonatal mice inoculated subcutane-
ously (s.c.) or intracerebrally (52, 57, 61). With the s.c. route of
infection, virus replication is first observed in skeletal muscle,
skin, and fibroblast-connective tissue, with virus becoming dis-
seminated throughout the animal by 24 h postinfection (hpi)
(14, 61). This early replication leads to virus invasion of the
central nervous system and infection of neurons (14, 51, 61).
Mortality has been ascribed to fatal encephalitis (14, 51). How-
ever, pathology studies have shown little evidence of T- or
B-cell-mediated disease with Sindbis virus (14, 15, 29, 61), and
neonatal immunodeficient scid mice also succumb to fatal dis-
ease (24). Neonatal mice infected intracerebrally with virus
constructs expressing inhibitors of apoptosis exhibit reduced
mortality (23, 35), suggesting a direct effect of virus replication
in neurons on disease outcome. In studies of other laboratory
strains, however, overwhelming virus replication and damage
in extraneural tissues have been implicated in the induction of
a potentially toxic inflammatory cytokine and stress mediator
cascade which is associated with neonatal mouse mortality but
occurs in the absence of frank encephalitis (61, 63). Therefore,
a number of factors may contribute to Sindbis virus-induced
mortality, depending upon the virus strain used, the route of
inoculation, and the age of the mouse at the time of infection
(51, 61, 63, 64).
A difficulty in interpreting these studies is that even virulent
laboratory isolates of Sindbis virus strain AR339 that cause
100% mortality contain mutations associated with attenuation
of disease in mice (31). Comparisons of laboratory viruses with
more extensively cell-adapted strains have resulted in the iden-
tification of several loci in the structural glycoproteins and at
least one in the 59 nontranslated region (NTR) that can influ-
ence neonatal mouse virulence (28, 31, 40, 51, 61). One class of
cell culture-adaptive mutations in the E2 glycoprotein confers
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the ability to use heparan sulfate (HS) as a cell attachment
receptor (19, 31). Such mutations arise very rapidly during
propagation of AR339 in cell culture (19). Therefore, cell
culture-adaptive attenuating mutations may well be embedded
in low-passage biological or cDNA-cloned laboratory strains
considered to be wild type.
TRSB, the low cell passage strain used in this laboratory,
does not induce frank encephalitis in neonatal mice. Instead,
the disease is characterized by extensive virus replication in
extraneural tissues and the induction of high levels of several
proinflammatory cytokines and corticosterone (61, 63), sugges-
tive of a systemic inflammatory response syndrome (SIRS) (1,
2, 5). This type of pathogenesis differs significantly from the
predominantly encephalitic disease course that has been asso-
ciated with Sindbis virus infection previously (14, 51). One
possible explanation for this difference is that the shock-like
syndrome and the lack of encephalitis in TRSB infection are an
artifact of cell culture-adaptive mutations unique to this labo-
ratory strain. A second explanation is that because the TRSB
sequence is very close to the consensus sequence of AR339,
differing by only three mutations, a systemic inflammatory re-
sponse may be characteristic of the fully virulent manifesta-
tions of Sindbis virus infection, while a more encephalitic
pathogenesis is associated with attenuated laboratory strains.
To test these alternative explanations, we have constructed a
cDNA clone comprised of the consensus sequence of Sindbis
virus strain AR339 (19, 31). Virus generated from this clone,
pTR339, which purges the sequence of several known cell
culture-adaptive mutations present in laboratory isolates of
Sindbis virus strain AR339, does not rely on HS attachment for
cell infection and is likely closer in sequence to the original
Sindbis virus strain AR339 isolate than are any of the labora-
tory strains (31). In the studies reported here, we have com-
pared the pathogenesis of TR339 in neonatal mice with the
pathogenesis of TRSB and a more highly cell culture-adapted
strain, HRsp (cDNA clone Toto 50). While these viruses rep-
licated in identical tissues, increased mortality and decreased
survival time were correlated with higher levels of virus repli-
cation and the increased magnitude of induction of proin-
flammatory cytokines, such as alpha/beta interferon (IFN-a/b),
tumor necrosis factor alpha (TNF-a), gamma interferon (IFN-g),
and interleukin-6 (IL-6), as well as systemic stress response
mediators. These findings strongly suggest (i) that the TR339-
infected mice had SIRS, (ii) that the SIRS response in the
absence of frank encephalitis contributes significantly to the
pathogenesis of fully virulent Sindbis virus strain AR339 in
neonatal mice, and (iii) that cell culture-adaptive mutations
conferring HS attachment contribute to the attenuation of
Sindbis virus laboratory strains.
MATERIALS AND METHODS
Viruses. Construction of the cDNA clones of the biological laboratory strain,
pTRSB, and the AR339 consensus sequence virus, pTR339, has been previously
described (19, 31). The “p” prefix refers to the plasmid form of the cloned virus.
The three coding differences present in pTR339, compared with pTRSB (Table
1), were introduced individually into the pTRSB background by restriction en-
donuclease fragment exchange from pTR339. Arginine at nsP3 position 528 was
obtained from a SpeI-to-HpaI fragment (clone designated pnsP3 528); serine at
E2 position 1 was obtained from a StuI-BssHII fragment (clone designated
pE2S1); and alanine at E1 position 72 was obtained from a BssHII-to-XhoI
fragment (clone designated pE1 72). pToto 50, a cDNA clone of the HRsp strain
of AR339 (43), was a gift from Charles Rice, Washington University, St. Louis,
Mo. All genetic manipulations were confirmed by DNA cycle sequencing (USB).
Virus stocks were generated by in vitro transcription of linearized cDNA tem-
plates, followed by electroporation of the transcripts into BHK-21 cells (Amer-
ican Type Culture Collection; maintained in alpha minimum essential medium
[GIBCO] supplemented with 10% donor calf serum, 10% tryptose phosphate
broth, L-glutamine, 100 U of penicillin per ml, and 0.05 mg of streptomycin per
ml). Electroporation supernatants were harvested after 18 to 20 h, clarified, and
stored at 270°C. Titers of electroporation stocks were determined by standard
plaque assay on BHK cells, and the stocks were used directly for mouse infection.
Mice. Pregnant outbred CD-1 females (13 to 15 or 15 to 17 days of gestation)
were obtained from Charles River Laboratories. Mice were infected s.c. with 103
PFU of each virus in 50 ml of virus buffer (VB; phosphate-buffered saline–1%
donor calf serum) at 12 to 24 h postnatally. Mice were sacrificed at 12-h intervals
through 72 hpi for virus titer determination and cytokine assays or observed at
12- or 24-h intervals through day 21 for mortality and average survival time
(AST).
Virus attachment and infectivity assays. Radiolabeling ([35S]methionine), pu-
rification of virus, and suspension binding assays were performed exactly as
previously described (19). This method was previously shown to give results
similar to those of cell monolayer binding assays with Sindbis virus (19). For
binding assays, BHK cells were dissociated from tissue culture plates using
enzyme-free cell dissociation buffer (GIBCO) and washed three times with VB
prior to reaction with virus. Fifty-microliter volumes of cells (;106) were added
to Eppendorf tubes, followed by 50-ml volumes of purified virus (105 cpm/
reaction mixture), and reaction mixtures were incubated at 4°C for 60 min with
gentle agitation. Cells then were washed three times with 1 ml of VB, and
radioactivity associated with cells was determined by scintillation counting. Cell-
free control reactions were run for each binding experiment, and the counts per
minute adherent to reaction tubes were subtracted from the total counts per
minute bound. Specific infectivity (number of PFU divided by counts per minute)
was calculated as previously described (19). Binding reactions were done in
duplicate or triplicate, and all experiments were repeated at least twice.
Virus, cytokine, and corticosterone titrations. Whole blood obtained from
mice was separated into serum and erythrocyte fractions by using Microtainer
serum separators (Becton-Dickinson). Serum samples were obtained from either
individual mice or a pool of 5 to 10 mice. Brains were removed, diluted 1:1 in VB,
homogenized, and centrifuged, and the clarified supernatant was aliquoted. All
samples were stored at 270°C prior to assay. Virus titers in serum and brain
samples were measured by standard plaque assay on BHK cells. The IFN-a/b
titer was determined by biological assay as previously described (61). Mouse
TNF-a was measured by using the Factor-X ELISA kit (Genzyme). IL-6 and
IFN-g were measured by enzyme-linked immunosorbent assay as previously
described (36, 38). Serum corticosterone was measured with a radioimmunoassay
kit (ICN).
Histopathology and ISH analysis. After euthanization, the cranial, thoracic,
and abdominal cavities of at least two mice per time point were opened and the
mice were immersion fixed in a 10% formalin solution (Fisher). Heads and
bodies, with the thymuses removed and processed separately, were bisected
midsagittally, embedded in paraffin, and then sectioned. Hematoxylin and eosin
(H&E)-stained tissues were examined by light microscopy. In situ hybridization
(ISH) analysis for sites of virus replication was performed essentially as described
by Trgovcich et al. (61). However, a negative control probe derived from the
EBER gene of Epstein-Barr virus (EBV) was used. Controls consisted of infect-
ed-mouse tissues incubated with the EBV probe and uninfected-mouse tissues
incubated with the virus-specific probe. Photomicrographs were taken on a
Nikon photomicroscope.
LPS treatment. Neonatal mice were injected intraperitoneally with lipopoly-
saccharide (LPS; Escherichia coli 111:226; Sigma) at 30 mg/kg in 20 ml of VB. In
preliminary titrations, this dose caused 95 to 100% mortality. LPS- and mock-
treated mice were sacrificed at 2, 4, 8, and 20 hpi for serum cytokine (5 to 10
mice, pooled) and histopathological (3 mice per time point) analyses as described
above. LPS-treated mice were also sacrificed for assay at 28 hpi.
TABLE 1. Amino acid differences and binding phenotypes of
viruses used in pathogenesis studies







TR339 Arg Ser Ala 7.4 6 1.1 5.6 6 0.2
TRSB Gln Arg Val 100.0 6 16.1 100.0 6 15.9
nsP3 528 Arg Arg Val 131.6 6 31.8 118.4 6 18.1
E2S1 Gln Ser Val 8.0 6 4.0 6.6 6 1.1
E1 72 Gln Arg Ala 89.5 6 15.4 68.3 6 3.74
Toto 50d Arg Ser Ala 372.8 6 81.9 539.3 6 86.3
a Viruses other than Toto 50 are isogenic except for the indicated loci.
b Relative binding to BHK cells; all values are normalized to TRSB 5 100.
c Relative numbers of BHK cell PFU per count per minute of radiolabeled
virus; all values are normalized to TRSB 5 100.
d Toto 50 differs from the consensus sequence at eight coding positions and
nucleotide 5 of the 59 NTR.
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RESULTS
Five noncoding and three coding differences distinguish the
Sindbis virus AR339 consensus sequence from that of our
laboratory strain cDNA clone, pTRSB (31) (Table 1). None of
the noncoding differences are located in identified alphavirus
cis-acting sequences, and they have not been considered as
candidate loci affecting pathogenesis. In comparison, the HRsp
(biological progenitor of clone Toto 50) sequence differs at
eight coding positions and at nucleotide 5 of the 59 NTR. Four
of these loci have been identified previously as affecting AR339
pathogenesis in mice (28, 31). Based on mortality and AST,
TR339 is the most virulent of these viruses, followed, in order
of decreasing virulence, by TRSB and Toto 50 (19, 51, 61). To
evaluate the relative contribution of each of the differences
between TRSB and TR339 to the greater virulence of TR339,
we have constructed cDNA clones with each TR339 difference
residue substituted separately into the TRSB background (Ta-
ble 1).
Binding to BHK cells. The Ser (TR339)-to-Arg (TRSB)
difference at position 1 of the E2 structural glycoprotein con-
fers a significant increase in binding of TRSB to BHK cells,
and this binding is dependent upon the presence of cell surface
HS (19). Binding studies with viruses differing at the three
coding positions that distinguish TRSB and TR339 indicated
that only the Ser-to-Arg change at E2 position 1 resulted in a
large difference in attachment to BHK cells (Table 1). The
specific infectivity of the viruses covaried with binding, suggest-
ing that the relative ability to establish infection of the cells was
determined by attachment efficiency (Table 1). The binding
and infectivity of Toto 50 were significantly greater than those
of the other viruses. Previous studies indicate that this virus
also attaches to HS receptors on cultured cells (13, 19). The
specific infectivity data suggest that in terms of the numbers of
PFU determined on BHK cells, virus particle-to-PFU ratios
are very different between these viruses, with Toto 50 , TRSB,
nsP3 528, and E1 72 , E2S1 and TR339. TR339 ranged from
20- to 100-fold less infectious per count per minute for BHK
cells than TRSB, and Toto 50 was 3- to 5-fold more infectious
for BHK cells than was TRSB. This suggests that BHK cell
plaque assays significantly underestimate the number of
TR339 particles relative to those of TRSB and Toto 50.
Virulence in neonatal mice. TR339 exhibited increased vir-
ulence over the laboratory strain virus TRSB, resulting in very
rapid death of all infected mice and a significant reduction in
AST (two-tailed Student t test, P , 0.01) compared with TRSB
(Fig. 1 and Table 2). When the three coding differences be-
tween TRSB and TR339 were evaluated individually, it was
found that substitution of the TR339 Ser for the TRSB Arg at
E2 position 1 was sufficient to confer virulence similar to that
of TR339 (P . 0.1). The residues at nsP3 position 528 and E1
position 72 had no significant effect on virulence (P . 0.4). In
comparison, Toto 50 showed only ;30% mortality and a
greatly extended AST, consistent with previous reports (51).
The differences among TRSB-like viruses, TR339-like vi-
ruses, and Toto 50 in specific infectivity for BHK cells (Table
1) indicate that mouse inocula comprised of equal numbers of
BHK PFU would contain more TR339-like virus particles.
However, in preliminary virus titration experiments, ASTs of
FIG. 1. Survival of neonatal mice infected with TR339 (Œ), E2S1 (■), TRSB
(h), nsP3 528 ({), E172 (E), or Toto 50 (1). Mice were infected s.c. with 1,000
PFU of each virus in 50 ml of virus diluent.
FIG. 2. Titers of virus in sera (A) and brains (B) of infected neonatal mice.
Symbols: h, TRSB; {, nsP3 528; E, E1 72; ■, E2S1; Œ, TR339; 1, Toto 50; p,
Toto 50 titer below the limit of detection of the plaque assay (3,500 PFU/ml).
TABLE 2. Mortality and AST of neonatal mice infected with the
viruses used in the current studies
Virus No. of mice Mortality (%) AST (days)
TR339 30 100 1.7 6 0.25
E2S1 30 100 1.9 6 0.53
TRSB 30 100 2.9 6 0.52
nsP3 528 32 100 2.8 6 0.55
E1 72 29 100 2.9 6 0.53
Toto 50 16 31.3 11.0 6 4.80
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TR339- and E2S1-infected neonates did not vary significantly
when mice were given between 1,000 and 0.01 BHK PFU (data
not shown). This indicates that TR339-like viruses are intrin-
sically more virulent than TRSB-like viruses. Similarly, the
AST and percent mortality of TRSB-infected mice did not vary
with decreasing dose (data not shown), confirming that Toto
50 particles are intrinsically less virulent regardless of the dose.
Virus replication in neonatal mice. Twelve- to 24-h-old
CD-1 mice were infected s.c. with 103 PFU of each virus listed
in Table 1. Mice were sacrificed at 12-h intervals through 72
hpi, and infectious virus titers in brain suspensions and serum
were determined on BHK cells. Consistent with the virulence
studies, serum virus titers indicated that TR339 replicated to
higher titers at all times postinfection (Fig. 2A) and that sub-
stitution of Ser for Arg at E2 position 1 in the TRSB back-
ground was sufficient to confer this phenotype. Virus with the
TR339 residues at nsP3 position 528 or E1 position 72 in the
TRSB background segregated with TRSB, and Toto 50 exhib-
ited lower titers at all times. As indicated by the cell infectivity
assays described above, BHK cell plaque assays likely under-
estimate the numbers of TR339 and E2S1 particles relative to
those of TRSB, nsP3 528, and E1 72 and similarly overestimate
the number of Toto 50 particles. Adjustment of the titration
results for BHK cell infectivity would increase TR339 and
E2S1 titers by 15- to 20-fold and decrease Toto 50 titers by 3-
to 5-fold. Likewise, while brain BHK cell titers indicated no
significant differences between TRSB and TR339 between 24
and 60 hpi, regardless of the residue at nsP3 position 528, E2
position 1, or E1 position 72 (Fig. 2B), adjustment for BHK
cell infectivity would indicate higher titers for TR339 and
E2S1. A clear lag in brain replication was seen at 12 hpi with
TRSB, nsP3 528, and E1 72, and replacing the consensus Ser
with Arg at TRSB E2 position 1 was sufficient to overcome the
lag. Even without BHK cell infectivity adjustment, Toto 50
brain titers were lowest at all times postinfection.
FIG. 3. IFN-a/b and TNF-a levels in pooled and individual sera of infected
neonatal mice. Levels in mock-infected animals were below the limits of detec-
tion for these assays. (A) IFN-a/b as measured in serum pools from 5 to 10 mice.
(B) TNF-a pooled samples (5 to 10 mice). Symbols: h, TRSB; {, nsP3 528; E,
E1 72; ■, E2S1; Œ, TR339; 1, Toto 50. (C) Peak IFN-a/b levels in sera of individual
mice (n 5 3). (D) Peak TNF-a levels in sera of individual mice (n 5 3). Levels in
mock-infected animals were below the limits of detection for these assays.
FIG. 4. IFN-g and IL-6 levels in pooled sera of infected neonatal mice.
Samples represent pooled sera from 5 to 10 mice that were mock infected (}) or
infected with TRSB (h), TR339 (Œ), or Toto 50 (1).
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Induction of proinflammatory cytokines and stress media-
tors. In infections of neonatal mice with TRSB and an atten-
uated mutant, a correlation was established among induction
of IFN-a/b, TNF-a, and corticosterone; a high virus titer; and
mortality (61, 63). The presence of TNF-a and corticosterone
suggested a previously unrecognized SIRS component in Sind-
bis virus disease. To test whether this pathology was an anom-
alous manifestation of one of the mutations present in TRSB
or whether the consensus sequence virus also was associated
with the shock-like syndrome, these parameters, as well as
IFN-g and IL-6, were measured in pooled animal sera at 12-h
intervals after infection. In addition, assays were performed on
sera of individual mice at 24, 36, and 48 hpi, times determined
in preliminary assays to correspond to peak cytokine induction
(data not shown). The results shown in Fig. 3 to 5 demonstrate
that TR339, comprising the consensus Sindbis virus AR339
sequence, induced an even more severe shock-like response
than TRSB and that the greater intensity of this response was
correlated with increased virulence.
Induction of IFN-a/b correlated with serum virus titer for all
of the viruses tested (Fig. 3A). This is consistent with previous
reports of IFN-a/b induction in Sindbis virus-infected mice
(e.g., reference 61). Comparing TR339 and TRSB, IFN-a/b
induction segregated with the Ser-Arg change at E2 position 1.
TR339- and E2S1-infected animals produced severalfold
higher IFN-a/b titers at all times postinfection, peaking at
nearly 2 3 106 IU/ml. Serum TNF-a levels also were closely
correlated with virulence (Fig. 3B). TR339 and E2S1 peak
values approached 4,000 pg/ml and were roughly twofold
higher than those of TRSB, nsP3 528, and E1 72. Infection with
Toto 50 produced low levels of IFN-a/b and TNF-a. For both
IFN-a/b and TNF-a, levels in individual mice were generally
consistent with those from pooled samples (Fig. 3C and D).
TR339 and E2S1 induced peak levels of TNF-a significantly
higher than those of TRSB, nsP3 528, and E1 72 (P # 0.02),
and these levels were significantly higher than that of Toto 50
(TRSB, P , 0.01; nsP3 528, P 5 0.03; E1 72, P , 0.01). Levels
of TNF-a similar to those for TRSB and TR339 have been
associated with a fatal outcome in LPS-treated adult mice and
in models of bacterial sepsis (4, 25, 50, 59), and high levels of
IFN-a/b cause liver, spleen, and thymus pathology in neonatal
mice (9).
Since measures of virulence such as AST, virus titer, and
induction of IFN-a/b and TNF-a segregate with the Ser-to-
Arg substitution at E2 position 1, one representative of each
group (TRSB or TR339) was analyzed further in combination
with Toto 50. The magnitude of IFN-g and IL-6 induction also
correlated with virus virulence (Fig. 4A and B). IFN-g was
produced in a burst at 24 hpi, with levels falling by 36 hpi,
perhaps revealing an early effect of stimulation of NK or T
cells. IL-6 induction increased during infection to levels ap-
proaching 10,000 pg/ml with TR339, almost twofold higher
than TRSB-induced levels. Although the kinetics of induction
were slightly variable between animals, IFN-g and IL-6 levels
in sera of individual mice were consistent with those in pooled
samples (data not shown), with TR339-induced levels signifi-
cantly higher than TRSB-induced levels (P 5 0.01 for IFN-g;
P , 0.01 for IL-6) and TRSB-induced levels significantly
higher than Toto 50-induced levels (P , 0.01 for both).
Induction of the systemic stress mediator corticosterone is
implicated in a feedback mechanism by which proinflammatory
cytokine responses are damped during septic shock, with pro-
duction of corticosterone potentially mediated through direct
action of IL-6 or IL-1b on the hypothalamic-pituitary axis (46,
47, 60). Corticosterone levels in pooled sera from TR339- and
TRSB-infected mice increased through 60 hpi, with levels in
TR339-infected mice rising earlier and to a higher peak level
and reflecting the virulence of the inducing virus (Fig. 5).
These results suggest that the proximal stress hormone-induc-
ing factor is closely correlated with virus replication. Pooled
samples from Toto 50-infected mice exhibited only mild stress
mediator induction with serum levels approximately 10-fold
lower than TRSB-induced levels and greater than 20-fold
lower than TR339-induced levels.
ISH and histopathological analyses. To determine if any
quantitative or qualitative differences in sites or extent of virus
replication correlated with virulence differences, tissue sec-
tions from TR339-, TRSB-, and Toto 50-infected mice were
evaluated by ISH for sites of viral RNA production. H&E-
stained sections were observed for pathological changes. Sec-
tions from mock-infected animals treated with the Sindbis vi-
rus-specific probe and virus-infected animals treated with an
EBV-specific probe showed no positive signal other than oc-
casional staining of keratinized skin epithelium (found with all
probes and in mock-infected animals), indicating that the ISH
signal was specific for sites of Sindbis virus genome expression.
At 12 hpi, a positive punctate ISH signal was seen consis-
tently in skin, periosteum, and skeletal muscle associated with
the site of inoculation in TR339-infected mice (data not
shown). In addition, an occasional signal was observed in sim-
ilar tissues distant from the inoculation site. With TRSB, the
virus signal was not seen consistently at the inoculation site and
was less intense and less widespread when observed. No ISH
signal was found at 12 hpi in mice infected with Toto 50, and
pathological changes were not observed with any of the viruses
at 12 hpi (data not shown).
By 24 hpi, TR339-infected mice exhibited a diffuse positive
signal in skeletal muscle and fibroblast-connective tissue
throughout the animal, extending into the tail, feet, legs, and
head. In addition, a focal signal was observed in the dermis of
the skin, brown fat, myocardium, heart valves (Fig. 6A), lungs,
liver, kidneys, diaphragm, spleen, and gastrointestinal tract
smooth muscle (data not shown). This was accompanied occa-
sionally by infiltration of mononuclear cells in skeletal muscle
and the heart. However, at this time, while virus titers could be
detected in brains (see above), only rare positive ISH signal
foci could be observed (data not shown). As described above,
proinflammatory cytokines and stress mediators were induced
significantly over the background by 24 hpi, apparently in the
absence of significant virus genome expression in the brain.
FIG. 5. Corticosterone levels in pooled sera of infected neonatal mice. Sam-
ples represent pooled sera from 5 to 10 mice infected with TRSB (h), TR339
(Œ), or Toto 50 (1) and mock-infected mice (}).
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FIG. 6. Histopathological and ISH analyses of virus-infected neonatal mice. (A) ISH showing virus replication in the myocardium and valves (arrow) of the heart
at 24 hpi (original magnification, 340). (B) ISH of the caudal portion of a midsagittal section through the body of a TR339-infected mouse sacrificed at 60 hpi (original
magnification, 310). Arrows indicate virus replication in the skeletal muscle (a), the diaphragm (b), and the muscularis of the gut (c). (C) ISH showing confluent virus
replication in skeletal muscle of a TR339-infected mouse at 60 hpi (original magnification, 3100). (D) ISH showing focal replication of Toto 50 at 48 hpi (original
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This suggests that virus replication in peripheral tissues is re-
sponsible for induction of cytokines measured in serum. TRSB
signal was present in virtually identical tissue types and sites;
however, the signal was less intense and less widespread. In
Toto 50-infected mice, the positive ISH signal was confined to
focal sites in skeletal muscle, the lungs, and connective tissue
and no signal was observed in the brain (data not shown).
The ISH signal was more widespread in TR339-infected
mice prior to 60 hpi, at which time the signal extent was
equivalent between TRSB and TR339 (Fig. 6B and C). By 60
hpi, an intense ISH signal was found in virtually all of the
skeletal muscle and fibroblast-connective tissue of the animals
(Fig. 6B and C). A signal also was observed in the myocardium
and heart valves (data not shown), the smooth muscle of the
intestinal tract, and the capsular-endothelial tissue of the liver,
kidneys, and lungs (Fig. 6B). H&E-stained sections revealed
widespread and dramatic necrosis and/or apoptosis of virus-
infected skeletal muscle in association with occasional mono-
nuclear cell infiltrates (Fig. 6E). In addition, apoptotic and/or
necrotic cells associated with occasional mononuclear cell in-
filtrates were noted in virus-infected esophageal muscle, lungs,
dermis of the skin (Fig. 7B), brown fat, and smooth muscle of
the intestinal tract. All types of tissue damage were more
common and more severe in TR339-infected animals. Dimi-
nution of subcutaneous fat was first observed at 24 hpi and was
striking in TRSB- and TR339-infected mice by 48 to 60 hpi,
compared to mock- or Toto 50-infected mice (Fig. 7A and B).
In the brain, sites of virus replication were widely distributed
at 60 hpi and were associated with cells of neuronal morphol-
ogy. However, infection was focal (Fig. 6F), in contrast to the
nearly complete infection of skeletal muscle and connective
tissue in the periphery (Fig. 6B and C), and neither inflamma-
tory changes, morphological signs of severe cellular necrosis or
apoptosis, nor extensive mononuclear cell infiltration was ap-
parent with either TR339 or TRSB infection (Fig. 6G). A slight
increase in the number of condensed and fragmented cell
nuclei was observed in the brains of virus-infected mice late in
infection (data not shown). However, similar changes were
occasionally seen in mock-infected animals and were also ob-
served in LPS-treated mice (see below). This was in contrast to
the severe damage associated with virus replication in the skin,
skeletal muscle, and connective tissue (Fig. 6E and 7B). Tissue
types exhibiting a positive signal in Toto 50-infected mice were
indistinguishable from those of mice infected with TRSB and
TR339; however, the virus signal was confined to focal sites,
was not associated with infiltrating cells, and did not appear to
have spread significantly after 36 hpi (Fig. 6D). H&E-stained
sections from Toto 50-infected mice at 6, 8, and 10 days postin-
fection also were examined. By 6 to 8 days, signs of encepha-
litis, such as perivascular cuffing, infiltration of mononuclear
cells, and focal tissue necrosis, were observed (Fig. 6H).
Consistent with previous reports (29, 61), severe lympholysis
in the absence of virus replication was noted in the thymuses of
mice infected with TRSB and TR339; however, this patholog-
ical change was mild to nonexistent in Toto 50- or mock-
infected animals (Fig. 7C to E). Severity of thymic lesions
correlated with virulence, as damage in TRSB-infected animals
was generally confined to cortical regions, while the thymuses
of TR339-infected animals exhibited nearly confluent lym-
pholysis. In addition, apoptosis and/or necrosis, either in the
complete absence of virus replication or in areas with occa-
sional ISH-positive cells, was observed in cells of bone marrow,
hematopoietic clusters of the liver (Fig. 7G and H), follicular
marginal zones of the spleen (Fig. 7I and J), and gut-associated
lymphoid tissue. As both TNF-a and corticosterone have been
implicated in the induction of apoptosis of hematopoietic and
lymphoid cells (12, 17), these characteristic SIRS lesions may
be a sensitive indicator of the magnitude of the host response
to infection with Sindbis virus.
Treatment of mice with LPS. High-dose LPS treatment of
mice causes mortality due to massive induction of proinflam-
matory cytokines such as TNF-a, IFN-g, IL-6, and IL-1b (re-
viewed in reference 2). LPS treatment has been used as a
model of SIRS in experimental animal models (reviewed in
reference 10). TNF-a has been directly implicated in mortality
due to shock, while IFN-g appears to prime cells to the cyto-
toxic effects of TNF-a (6, 16) and to increase induction of
TNF-a (7). Major pathophysiological changes associated with
induction of TNF-a or administration of TNF-a or LPS to
adult animals include tachypnea; hypotension; blood acidosis;
diminished cardiac output; focal hemorrhage in the lungs, ad-
renal glands, and pancreas; frank necrosis of the bowel asso-
ciated with polymorphonuclear cell infiltration and focal loss of
epithelium; tubular necrosis of the kidneys; occlusion of pul-
monary arteries by polymorphonuclear cells; disseminated in-
travascular coagulation; apoptosis of thymocytes, bone marrow
cells, and splenocytes; and disruption of adipocyte metabolism
(58, 59).
To determine the relationship of pathology associated with
the LPS-induced SIRS model to that found in TR339-infected
neonatal mice, mice were treated with lethal doses of LPS and
then H&E-stained tissue sections and cytokine and stress me-
diator profiles were evaluated. Virtually all of the mice that
succumbed to the LPS treatment did so prior to 30 hpi (data
not shown). Similar to virulent Sindbis virus-infected mice,
LPS-treated neonatal mice exhibited cellular changes morpho-
logically consistent with apoptosis in the thymus, bone marrow,
spleen, gut-associated lymphoid tissue, and hematopoietic
clusters in the liver. Thymocyte damage was first evident at 4
hpi, becoming severe by 20 hpi. However, lympholysis was
frequently confined to cortical regions, as opposed to the con-
fluent lympholysis observed with TR339-infected mice after 48
hpi (Fig. 7F). Other similarities between virus-infected and
LPS-treated mice included an increase in condensed and frag-
mented cell nuclei in the brain and a marked diminution of
subcutaneous fat (data not shown). However, frank necrosis of
the bowel, loss of intestinal epithelium, and infiltration of
mononuclear cells into the intestinal mucosa, submucosa, and
lungs, as described for adult animals treated with LPS, were
not found in neonatal mice.
Cytokine induction in response to LPS treatment exhibited
both quantitative and qualitative differences from the response
to virus infection. TNF-a and IL-6 were induced by 2 hpi and
reached peak levels greater than 10-fold and 5-fold higher than
in TR339-infected mice, respectively (Fig. 8A and B). Levels of
both cytokines returned to the baseline between 8 and 20 hpi
magnification, 3100). Dark staining of keratinized epithelium was present in mock-infected animals and is not a consequence of virus replication. (E) H&E-stained
section of skeletal muscle from a TR339-infected mouse sacrificed at 60 hpi. The arrow indicates condensed nuclei of muscle cells (original magnification, 3400). (F)
ISH of a midsagittal section through the head of a TR339-infected mouse sacrificed at 60 hpi (original magnification, 3100). The arrow indicates the focus of the ISH
signal over intact cells with neuronal morphology. (G) H&E-stained adjacent serial section from the area pictured in panel F. The arrow indicates the area of virus
replication identified by ISH (original magnification, 3200). (H) H&E-stained section from the brain of a Toto 50-infected mouse 8 days postinfection showing
perivascular cuffing and infiltration of mononuclear cells (original magnification, 3400).
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FIG. 7. Histopathological analysis of virus-infected and LPS-treated neonatal mice. (A) Skin of a Toto 50-infected mouse sacrificed at 48 hpi which was
indistinguishable from that of mock-infected controls (the arrow indicates subcutaneous fat deposits) (original magnification, 3200). (B) Analogous section from a
TR339-infected mouse sacrificed at 48 hpi (the arrow indicates apoptotic and/or necrotic cells in the dermis of the skin) (original magnification, 3200). (C to F) Arrows
indicate the thymus cortex, and double arrows indicate the medulla. (C) Thymus from a Toto 50-infected mouse sacrificed at 48 hpi (original magnification, 3400).
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(prior to the time of death of most animals), in contrast to
those of virus-infected mice, which exhibited elevated TNF-a
at all times after 12 hpi. In LPS-treated mice, IFN-g levels rose
after 4 hpi, peaking at levels similar to those found in TR339-
infected mice (Fig. 8C), while corticosterone levels increased
by 2 hpi and remained elevated through 28 hpi (Fig. 8D). In
contrast to those of virus-infected mice, IFN-a/b levels did not
rise significantly (data not shown).
DISCUSSION
These studies have utilized a genetic approach to determine
if the shock-like induction of TNF-a and corticosterone that is
characteristic of TRSB infection (61, 63) is (i) an anomalous
manifestation of cell-adaptive mutations in this laboratory
strain of Sindbis virus or (ii) a previously unrecognized pathol-
ogy reflective of Sindbis virus strains closer to the native Sind-
bis virus sequence. To test this hypothesis, the pathogenesis of
TRSB was compared with that of TR339, a virus representing
the consensus sequence of Sindbis virus AR339 strains. In
addition, TRSB pathogenesis was compared to that of Toto 50,
a virus with even greater divergence from the consensus se-
quence.
TRSB infection was characterized by disseminated virus rep-
lication in skeletal muscle and fibroblast-connective tissue, fol-
lowed by invasion of and widespread replication in the central
nervous system. Virus replication resulted in induction of high
levels of TNF-a, IFN-g, IFN-a/b, IL-6, and corticosterone in
serum, reminiscent of cytokine induction during LPS-induced
shock or gram-negative bacterial sepsis (reviewed in reference
2), two causes of SIRS (1, 5). Reduction of the divergence from
the consensus sequence led to a SIRS disease even more in-
tense than that caused by TRSB. The Sindbis virus AR339
consensus sequence virus, TR339, produced higher titers in
serum, spread more rapidly within the mouse, and resulted in
the induction of higher levels of proinflammatory cytokines
that correlated with significantly reduced survival time.
FIG. 8. TNF-a, IFN-g, IL-6, and corticosterone levels in pooled sera of LPS-treated neonatal mice. TNF-a (A), IL-6 (B), IFN-g (C), and corticosterone (D) levels
in pooled sera from 5 to 10 LPS-treated (F) and mock-treated (}) neonatal mice are shown.
(D) Thymus from a TRSB-infected mouse sacrificed at 60 hpi (original magnification, 3400). (E) Thymus from a TR339-infected mouse sacrificed at 60 hpi (original
magnification, 3400). (F) Thymus from an LPS-treated mouse sacrificed at 28 hpi (original magnification, 3400). (G) Section through the liver of a mock-infected
mouse sacrificed at 60 hpi. The arrow indicates a cluster of hematopoietic cells (original magnification, 3400). (H) Analogous section from a TR339-infected mouse
sacrificed at 60 hpi. The arrow indicates the condensed nucleus of a hematopoietic cell (original magnification, 3400). (I) Spleen section from a mock-infected mouse
sacrificed at 48 hpi. The arrow indicates the follicle marginal zone (original magnification, 3400). (J) Analogous section from a TR339-infected mouse sacrificed at
48 hpi. The arrow indicates condensed and fragmented nuclei in the marginal zone (original magnification, 3400).
VOL. 73, 1999 SINDBIS VIRUS INFECTION OF MICE CAUSES SIRS 10395
Conversely, increased divergence from the consensus se-
quence diminished the SIRS disease signs and led to enceph-
alitic pathology. The extensively divergent Toto 50 produced
the lowest virus titers, limited cytokine induction, and signs of
encephalitis with little pathological evidence of SIRS. This was
correlated with extended survival time and reduced mortality
relative to those obtained with TRSB.
Virulence differences between TRSB and TR339 were
mapped to a single amino acid polymorphism at position 1 of
the E2 structural glycoprotein (Ser in TR339, Arg in TRSB).
The E2 Arg at position 1 conferred a large increase in binding
to BHK cells and to a number of other cultured cell types. This
binding was previously shown to be dependent upon cell sur-
face HS (18, 19). Likewise, Toto 50 bound to BHK cells three-
to fivefold more efficiently than did TRSB. This virus contains
a mutation (Glu to Lys at E2 position 70) which confers at-
tachment to HS (18, 19). Hence, the presence of mutations
that confer HS-dependent attachment to cells is correlated
with attenuation of the SIRS disease in neonatal mice, most
likely arising from reduced rates and extents of virus replica-
tion within infected mice. However, the severely attenuated
phenotype of Toto 50 likely results not only from the E2
position 70 Lys mutation but also from other mutations at loci
in E1, E2, and the 59 NTR previously shown to affect virulence
in mice.
Cytokine profiles and induced pathology in virus-infected
and LPS-treated mice. The cytokine and stress mediator pro-
files observed in these and related studies (61, 63) suggest a
connection between the early host response to Sindbis virus
infection and mouse mortality. In studies in which proinflam-
matory cytokine responses to Sindbis virus infection have been
measured by quantitative techniques, increased peak levels of
cytokines in serum have always correlated with increased mor-
tality and/or decreased AST (48, 62, 63). In addition, the levels
of TNF-a present in sera of TR339- and TRSB-infected mice
are similar to those reported in SIRS models such as fatal LPS
treatment of adult mice and with fatal gram-negative sepsis (4,
25, 50, 60). However, in contrast to transient TNF-a produc-
tion in LPS-induced shock, mice infected with highly virulent
Sindbis virus strains exhibited elevated levels of TNF-a that
persisted until death. Sustained levels of TNF-a are closely
correlated with mortality in human sepsis studies (4).
Characteristic histological signs of LPS- or TNF-a-mediated
(SIRS) pathology, i.e., thymic involution, apoptosis in the
spleen and bone marrow, destruction of hematopoietic cells in
the liver, and depletion of adipocytes were present in TRSB-
infected mice in the absence of colocalized virus replication.
Consistent with higher inflammatory cytokine levels in TR339-
infected mice, all of these signs were more severe. Such patho-
logical changes in TR339-infected mice were similar to or
more severe than in mice treated with lethal doses of LPS. In
contrast, TNF-a and IL-6 induction in LPS-treated neonates
was significantly greater than that observed with TR339 infec-
tion but of shorter duration, consistent with reported differ-
ences between LPS-treated and septic animals (2). Together,
these results provide a strong circumstantial case for involve-
ment of SIRS in disease induced by virulent Sindbis virus.
There also may be significant differences between conven-
tional shock-sepsis models and the disease produced in Sindbis
virus-infected neonatal mice. Murine cytomegalovirus infec-
tion of mice produces a qualitatively different inflammatory
response than LPS-induced shock in that murine cytomegalo-
virus induces corticosterone by an IL-6-dependent pathway
while LPS-induced corticosterone is IL-6 independent (46). In
the Sindbis virus model, we have been unable to reliably detect
higher levels of IL-1b in infected animals compared to mock-
infected controls (data not shown). This result, in combination
with the induction of high levels of IFN-a/b only in virus-
infected mice, indicates possible qualitative differences be-
tween SIRS induced by LPS and that induced by Sindbis virus.
Likewise, as few studies have evaluated in detail the effect of
high levels of proinflammatory cytokines on neonatal animals,
there may be significant differences in their responses com-
pared to those of adults. Consistent with the results described
in this report, previous treatment of neonatal mice with re-
combinant TNF-a failed to produce the characteristic lung and
gastrointestinal tract pathology associated with high levels of
TNF-a in adult animals (9). In addition, limited inflammatory
cell infiltrates in LPS-treated and Sindbis virus-infected neo-
natal mice may reflect defects in polymorphonuclear cell acti-
vation, chemotaxis, and production of several cytokines docu-
mented for neonatal animals (21, 26, 30, 32).
Cytokine-mediated cell damage. We observed condensed
and fragmented cell nuclei in many peripheral tissues of
TRSB- and TR339-infected mice, both in association with and
in the absence of virus replication. Similar, although much less
extensive, pathological changes were observed in the brains of
LPS-treated and virus-infected mice. Induction of proinflam-
matory cytokines has been associated with potentiation of both
apoptotic and necrotic tissue injury in animal models of viral
and other diseases (8, 33, 34, 39, 42, 45, 49, 56, 60). Apoptosis
has been documented in the intestines, livers, lungs, fat, thy-
muses, and endothelial cells of LPS- and TNF-a-treated mice
(3, 11) and in one study was causally linked to mortality (11).
In neonatal infections, the blood-brain barrier may be more
permeable (53) and permeability can be enhanced by circulat-
ing cytokines (27, 41). Hence, cells in the neonatal central
nervous system may be subject to effects of host factors se-
creted into the blood, contributing to pathological changes
observed with Sindbis virus infection or LPS treatment.
Moreover, virus infection of cells may alter responses to
cytokines. In vitro and in vivo sensitivity to TNF-a-mediated
cytotoxicity is greatly enhanced by inhibitors of cellular tran-
scription and/or translation (3, 22, 33, 54), and infection with
several viruses sensitizes cells to the cytotoxic effects of TNF-a
(20, 37, 44). A primary effect of Sindbis virus infection is
repression of host cell transcription, DNA replication, and
translation (55). It is possible that Sindbis virus-infected cells
have altered sensitivity to the effects of TNF-a or other circu-
lating host factors.
Proximal cause of death due to Sindbis virus infection. A
particularly complicating factor in these neonatal mouse stud-
ies may be the relatively unrestrained replication of virulent
Sindbis virus, leading to extensive damage to virus-infected
cells and extensive damage to cells as a consequence of proin-
flammatory cytokine induction. Fatal outcome may reflect the
cooperative activities of several pathologic mechanisms, any
one of which could result in mortality if allowed to manifest
fully. However, these studies suggest that SIRS is a major
contributing factor in virulent Sindbis virus disease in which
disseminated infection results in multiple pathological condi-
tions and rapid death. Moreover, the SIRS component of Sind-
bis virus-induced disease in neonatal animals is observed only
with strains closely reflecting the consensus sequence of the
virus and not with strains extensively adapted to cell culture
replication. This underscores the necessity of the identification
and elimination of the effects of tissue culture adaptation on
viral strains used in animal models of disease.
ACKNOWLEDGMENTS
This work was supported by Public Health Service-NIH grants
AI22186 and CA41268. W.B.K. was supported by an NIH predoctoral
10396 KLIMSTRA ET AL. J. VIROL.
traineeship (T32 AI07419) and by the U.S. Army Research Office
(DAAH04-95-1-0224).
REFERENCES
1. American College of Chest Physicians/Society of Critical Care Medicine.
1992. Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. Crit. Care Med. 1992:864–874.
2. Billiau, A., and F. Vandekerckhove. 1991. Cytokines and their interactions
with other inflammatory mediators in the pathogenesis of sepsis and septic
shock. Eur. J. Clin. Investig. 21:559–573.
3. Bohlinger, I., M. Leist, F. Gantner, S. Angelmuller, G. Tiegs, and A. Wendel.
1996. DNA fragmentation in mouse organs during endotoxic shock. Am. J.
Pathol. 149:1381–1393.
4. Calandra, T., J.-D. Baumgartner, G. E. Grau, M.-M. Wu, P.-H. Lambert, J.
Schellekens, J. Verhoef, M. P. Glauser, and The Swiss-Dutch J5 Immuno-
globulin Study Group. 1990. Prognostic values of tumor necrosis factor/
cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the se-
rum of patients with septic shock. J. Infect. Dis. 161:982–987.
5. Davies, M. G., and P.-O. Hagen. 1997. Systemic inflammatory response
syndrome. Br. J. Surg. 84:920–935.
6. Dealtry, G. B., M. S. Naylor, W. Fiers, and F. R. Balkwill. 1987. DNA
fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced
by interferon-gamma. Eur. J. Immunol. 17:689–693.
7. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh,
and J. A. Norton. 1992. Evidence for IFN-gamma as a mediator of the
lethality of endotoxin and tumor necrosis factor-alpha. J. Immunol. 149:
1666–1670.
8. Grau, G., L. F. Fajardo, P.-F. Piguet, B. Allet, P.-H. Lambert, and P. Vas-
salli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in
murine cerebral malaria. Science 237:210–213.
9. Gresser, I., D. Woodrow, J. Moss, C. Maury, J. Tavernier, and W. Fiers.
1987. Toxic effects of recombinant tumor necrosis factor in suckling mice.
Am. J. Pathol. 128:13–18.
10. Gutierrez-Ramos, J. C., and H. Bluethmann. 1997. Molecules and mecha-
nisms operating in septic shock: lessons from knockout mice. Immunol.
Today 18:329–334.
11. Haimovitzfriedman, A., C. Cordoncardo, S. Bayoumy, M. Garzotto, M.
McLoughlin, R. Gallily, C. K. Edwards, E. H. Schuchman, Z. Fuks, and R.
Kolesnick. 1997. Lipopolysaccharide induces disseminated endothelial apo-
ptosis requiring ceramide generation. J. Exp. Med. 186:1831–1841.
12. Hernandez-Caselles, T., and O. Stutman. 1993. Immune functions of tumor
necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymo-
cytes and can also stimulate or inhibit IL-6-induced proliferation depending
on the type of mitogenic costimulation. J. Immunol. 151:3999–4012.
13. Jan, J. T., A. P. Byrnes, and D. E. Giffin. 1999. Characterization of a Chinese
hamster ovary cell line developed by retroviral insertional mutagenesis that
is resistant to Sindbis virus infection. J. Virol. 73:4919–4924.
14. Johnson, R. T. 1965. Virus invasion of the central nervous system: a study of
Sindbis virus infection of the mouse using fluorescent antibody. Am. J.
Pathol. 46:929–943.
15. Johnson, R. T., H. F. McFarland, and S. E. Levy. 1972. Age-dependent
resistance to viral encephalitis: studies of infections due to Sindbis virus in
mice. J. Infect. Dis. 125:257–262.
16. Kato, Y., A. Morikawa, T. Sugiyama, N. Koide, G.-Z. Jiang, T. Lwin, T.
Yoshida, and T. Yokochi. 1997. Augmentation of lipopolysaccharide-induced
thymocyte apoptosis by interferon-gamma. Cell. Immunol. 177:103–108.
17. Kato, Y., A. Morikawa, T. Sugiyama, N. Koide, G.-Z. Jiang, T. Takahashi,
and T. Yokochi. 1995. Role of tumor necrosis factor-alpha and glucocorticoid
on lipopolysaccharide (LPS)-induced apoptosis of thymocytes. FEMS Im-
munol. Med. Microbiol. 12:195–204.
18. Klimstra, W. B., H. W. Heidner, and R. E. Johnston. 1999. The furin pro-
tease cleavage recognition sequence of Sindbis virus PE2 can mediate virion
attachment to cell surface heparan sulfate. J. Virol. 73:6299–6306.
19. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of
Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment
receptor. J. Virol. 72:7357–7366.
20. Koff, W. C., and A. V. Fann. 1986. Human tumor necrosis factor-alpha kills
herpesvirus-infected but not normal cells. Lymphokine Res. 5:215–221.
21. Krause, P. J., J. Kristie, W. P. Wang, L. Eisenfeld, V. C. Herson, E. G.
Maderazo, K. Jozaki, and D. L. Kreutzer. 1987. Pentoxifylline enhancement
of defective neutrophil function and host defense in neonatal mice. Am. J.
Pathol. 129:217–222.
22. Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor
can induce both apoptotic and necrotic forms of cell lysis. J. Immunol.
141:2629–2634.
23. Levine, B., J. E. Goldman, H. H. Jiang, D. E. Griffin, and J. M. Hardwick.
1996. Bcl-2 protects mice against fatal alphavirus encephalitis. Proc. Natl.
Acad. Sci. USA 93:4810–4815.
24. Levine, B., and D. E. Griffin. 1993. Molecular analysis of neurovirulent
strains of Sindbis virus that evolve during persistent infection of scid mice.
J. Virol. 67:6872–6875.
25. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. Mc-
Dowell, M. Paskind, L. Rodman, J. Salfield, E. Towne, D. Tracey, S. Ward-
well, F.-Y. Wei, W. Wong, R. Kamen, and T. Seshardi. 1995. Mice deficient
in IL-1B-converting enzyme are defective in production of mature IL-1B and
resistant to endotoxic shock. Cell 80:401–411.
26. Liechty, K. W., K. R. Schibler, R. K. Ohls, S. L. Perkins, and R. D. Chris-
tensen. 1993. The failure of newborn mice infected with Escherichia coli to
accelerate neutrophil production correlates with their failure to increase
transcripts for granulocyte-colony stimulating factor and interleukin-6. Biol.
Neonate 64:331–340.
27. Lustig, S., H. D. Danenberg, Y. Kafri, D. Kobiler, and D. Ben-Nathan. 1992.
Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its
mediators. J. Exp. Med. 176:707–712.
28. Lustig, S., A. C. Jackson, C. S. Hahn, D. E. Griffin, E. G. Strauss, and J. H.
Strauss. 1988. Molecular basis of Sindbis virus neurovirulence in mice.
J. Virol. 62:2329–2336.
29. Mahlerbe, H., M. Strickland-Chomley, and A. L. Jackson. 1963. Sindbis virus
infection in man: report of a case with recovery of virus from skin lesions. S.
Afr. Med. J. 37:547–552.
30. Martin, T. R., J. T. Ruzinski, C. B. Wilson, and S. J. Skerrett. 1995. Effects
of endotoxin in the lungs of neonatal rats: age-dependent impairment of the
inflammatory response. J. Infect. Dis. 171:131–144.
31. McKnight, K. L., D. A. Simpson, S. C. Lin, T. A. Knott, J. M. Polo, D. F.
Pence, D. B. Johannsen, H. W. Heidner, N. L. Davis, and R. E. Johnston.
1996. Deduced consensus sequence of Sindbis virus strain AR339: mutations
contained in laboratory strains which affect cell culture and in vivo pheno-
types. J. Virol. 70:1981–1989.
32. Merry, C., P. Puri, and D. J. Reen. 1996. Defective neutrophil actin poly-
merization and chemotaxis in stressed newborns. J. Pediatr. Surg. 31:481–
485.
33. Morikawa, A., T. Sugiyama, Y. Kato, N. Kiode, G.-Z. Jiang, K. Takahashi, Y.
Tamada, and T. Yokochi. 1996. Apoptotic cell death in the response of
D-galactosamine-sensitized mice to lipopolysaccharide as an experimental
endotoxic shock model. Infect. Immun. 64:734–738.
34. Nagano, I., S. Nakamura, M. Yoshioka, J. Onodera, K. Kogure, and Y.
Itoyama. 1994. Expression of cytokines in brain lesions in subacute sclerosing
panencephalitis. Neurology 44:710–715.
35. Nava, V. E., A. Rosen, M. A. Veliuona, R. J. Clem, B. Levine, and J. M.
Hardwick. 1997. Sindbis virus induces apoptosis through a caspase-depen-
dent CrmA-sensitive pathway. J. Virol. 72:452–459.
36. Nguyen, K. B., and C. A. Biron. 1999. Synergism for cytokine-mediated
disease during concurrent endotoxin and viral challenges: role for NK and T
cell IFN-g production. J. Immunol. 162:5238–5246.
37. Ohno, K., T. Nakano, Y. Matsumoto, T. Watari, R. Goitsuka, H. Nakayama,
H. Tsujimoto, and A. Hasegawa. 1993. Apoptosis induced by tumor necrosis
factor in cells chronically infected with feline immunodeficiency virus. J. Vi-
rol. 67:2429–2433.
38. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement
for IL-12 in natural killer cell IFN-gamma production and antiviral defense.
J. Immunol. 156:1138–1142.
39. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, and C. A. Biron. 1997.
Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated
pathology independent of natural killer and T cells during murine cytomeg-
alovirus infection. J. Virol. 71:9248–9258.
40. Polo, J. M., and R. E. Johnston. 1990. Attenuating mutations in glycopro-
teins E1 and E2 of Sindbis virus produce a highly attenuated strain when
combined in vitro. J. Virol. 64:4438–4444.
41. Quagliarello, V. J., B. Wispelwey, W. J. J. Long, and W. M. Scheld. 1991.
Recombinant interleukin-1 induces meningitis and blood brain barrier injury
in the rat. Characterization and comparison with tumor necrosis factor.
J. Clin. Investig. 87:1360–1366.
42. Relton, J. K., and N. J. Rothwell. 1992. Interleukin-1 receptor antagonist
inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull.
29:243–246.
43. Rice, C. M., R. Levis, J. H. Strauss, and H. V. Huang. 1987. Production of
infectious RNA transcripts from Sindbis virus cDNA clones: mapping of
lethal mutations, rescue of a temperature-sensitive marker, and in vitro
mutagenesis to generate defined mutants. J. Virol. 61:3809–3819.
44. Rood, P. A., R. M. Lorence, and K. W. Kelley. 1990. Serine protease inhibitor
abrogation of Newcastle disease virus enhancement of cytolysis by recombi-
nant tumor necrosis factors alpha and beta. J. Natl. Cancer Inst. 82:213–217.
45. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L.
Grunnet, and S. J. Padula. 1990. An antibody to lymphotoxin and tumor
necrosis factor prevents transfer of experimental allergic encephalomyelitis.
J. Exp. Med. 172:1193–1200.
46. Ruzek, M. C., A. H. Miller, S. M. Opal, B. D. Pearce, and C. A. Biron. 1997.
Characterization of early cytokine responses and an IL-6-dependent pathway
of endogenous glucocorticoid induction during murine cytomegalovirus in-
fection. J. Exp. Med. 185:1185–1192.
47. Ruzek, M. C., B. D. Pearce, A. H. Miller, and C. A. Biron. 1999. Endogenous
glucocorticoids protect against cytokine-mediated lethality during viral in-
fection. J. Immunol. 162:3527–3533.
48. Ryman, K. D., and R. E. Johnston. 1997. Unpublished observations.
VOL. 73, 1999 SINDBIS VIRUS INFECTION OF MICE CAUSES SIRS 10397
49. Saukkonen, K., S. Sande, C. Cioffe, S. Wolpe, B. Sherry, A. Cerami, and E.
Toumanan. 1990. The role of cytokines in the generation of inflammation
and tissue damage in experimental gram-positive meningitis. J. Exp. Med.
171:439–448.
50. Shapria, L., W. A. Soskolne, Y. Houri, V. Barak, A. Halabi, and A. Stabholz.
1996. Protection against endotoxic shock and lipopolysaccharide-induced
local inflammation by tetracycline: correlation with inhibition of cytokine
secretion. Infect. Immun. 64:825–828.
51. Sherman, L. A., and D. E. Griffin. 1990. Pathogenesis of encephalitis induced
in newborn mice by virulent and avirulent strains of Sindbis virus. J. Virol.
64:2041–2046.
52. Simpson, D. A., N. L. Davis, S. C. Lin, D. Russell, and R. E. Johnston. 1996.
Complete nucleotide sequence and full-length cDNA clone of S.A.AR86, a
South African alphavirus related to Sindbis. Virology 222:464–469.
53. Skultetyova, I., D. I. Tokarev, and D. Jezova. 1993. Albumin content in the
developing rat brain in relation to the blood-brain barrier. Endocr. Regul.
27:209–213.
54. Slowik, M. R., W. Min, T. Ardito, A. Karsan, M. Kashagarian, and J. S.
Pober. 1997. Evidence that tumor necrosis factor triggers apoptosis in human
endothelial cells by interleukin-1-converting enzyme-like protease-depen-
dent and -independent pathways. Lab. Investig. 77:257–267.
55. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression,
replication, and evolution. Microbiol. Rev. 58:491–562.
56. Talley, A., S. Perry, L. G. Epstein, and H. A. Gelbard. 1994. TNFa-mediated
apoptosis in SK-N-MC neuroblastoma cells: a model for neuronal cell loss in
HIV-1-associated dementia. Ann. Neurol. 36:506–507.
57. Taylor, R. M., H. S. Hurlbut, T. H. Work, J. R. Kingston, and T. E. Roth-
ingham. 1955. Sindbis virus: a newly recognized arthropod-transmitted virus.
Am. J. Trop. Med. Hyg. 4:844–862.
58. Torti, F. M., B. Dieckmann, B. Beutler, A. Cerami, and G. M. Ringold. 1985.
A macrophage factor inhibits adipocyte gene expression: an in vitro model of
cachexia. Science 229:867–869.
59. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W.
Milsark, R. J. Hariri, T. J. Fahey, A. Zentella, J. D. Albert, G. T. Shires, and
A. Cerami. 1986. Shock and tissue injury induced by recombinant human
cachectin. Science 234:470–474.
60. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo,
S. F. Lowry, and A. Cerami. 1987. Anti cachectin/TNF monoclonal antibod-
ies prevent septic shock during lethal bacteraemia. Nature 330:662–664.
61. Trgovcich, J., J. F. Aronson, and R. E. Johnston. 1996. Fatal Sindbis virus
infection of neonatal mice in the absence of encephalitis. Virology 224:73–
83.
62. Trgovcich, J., and R. E. Johnston. TNF a, interferon and stress response
induction as a function of age-related susceptibility to fatal Sindbis virus
infection of mice. Virology, in press.
63. Trgovcich, J., K. Ryman, P. Extrom, J. C. Eldridge, J. F. Aronson, and R. E.
Johnston. 1997. Sindbis virus infection of neonatal mice results in a severe
stress response. Virology 227:234–238.
64. Tucker, P. C., E. G. Strauss, R. J. Kuhn, J. H. Strauss, and D. E. Griffin.
1993. Viral determinants of age-dependent virulence of Sindbis virus for
mice. J. Virol. 67:4605–4610.
10398 KLIMSTRA ET AL. J. VIROL.
